iCAD (ICAD) to Release Earnings on Monday

iCAD (NASDAQ:ICAD - Get Free Report) is anticipated to issue its quarterly earnings data before the market opens on Monday, March 10th. Analysts expect the company to announce earnings of ($0.05) per share and revenue of $4.72 million for the quarter.

iCAD Stock Performance

ICAD remained flat at $2.24 on Friday. 274,163 shares of the company traded hands, compared to its average volume of 248,690. The stock has a market cap of $59.45 million, a price-to-earnings ratio of -17.23 and a beta of 1.95. The stock's 50-day simple moving average is $2.59 and its two-hundred day simple moving average is $2.01. iCAD has a 12-month low of $1.18 and a 12-month high of $3.78.

Wall Street Analyst Weigh In

Separately, StockNews.com upgraded shares of iCAD from a "sell" rating to a "hold" rating in a report on Thursday, February 20th.

iCAD Company Profile

iCAD, Inc engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis.